Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Social Decision-Making in PD with Dopamine Agonists
NCT04249544Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of pramipexole in Parkinson's disease (PD) (4 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Change in a harm aversion cognitive moral decision-making task at 2 weeks and Change in blood flow in the ventral striatum per ASL images at 2 weeks. Started Dec 2019; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04249544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249544.